Yuyu Pharma Incorporated operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yuyu Pharma Incorporated with three other
pharmaceutical manufacturers in Asia:
Advanced Enzyme Technologies Ltd
sales of 3.31 billion Indian Rupees [US$51.46 million]
Albert David Limited
(3.16 billion Indian Rupees [US$49.11 million]
Taiko Pharmaceutical Company., Limited
based in Japan
(8.29 billion Japanese Yen [US$74.16 million]
of which 61%
was Medicine Goods).
During the year ended March of 2017, sales at
Yuyu Pharma Incorporated were 71.58 billion Korean Won (US$63.92 million).
increase of 2.6%
versus 2016, when the company's sales were 69.74 billion Korean Won.
This was the fifth consecutive year of sales increases at Yuyu Pharma Incorporated
(and since 2012, sales have increased a total of 22%).